Skip to content
DraconiticResearch
Search Sources API
182,460 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYFrontiers in veterinary science

Short-course letrozole restores fertility in aged azoospermic dogs.

  1. 1Suzhou Biosynium Corporation, Suzhou, Jiangsu, China.
  2. 2School of Public Health, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China.
  3. 3School of Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China.

Abstract

Introduction

Age-related azoospermia is a clinically important cause of male infertility in dogs, yet effective pharmacological treatments for aged males remain limited. Whether transient aromatase inhibition can restore fertility in aged azoospermic dogs without prolonged exposure is unclear.Methods

This study evaluated whether a 1-week course of letrozole, an aromatase inhibitor, could restore spermatogenesis and fertility in aged azoospermic male dogs. Untreated aged azoospermic and young fertile dogs served as comparison groups, and a separate cohort of five aged dogs received 3 months of letrozole for safety assessment. Serum testosterone, semen parameters, testicular histology, fertilization-related transcripts, spermatogonia, seminal plasma metabolites, and serum biochemical markers of liver, kidney, and bone metabolism were assessed before and after treatment over a 6-month follow-up.Results

Serum testosterone increased within 1 week and peaked at approximately 2 weeks. Spermatozoa reappeared in ejaculates approximately 3 months after treatment and persisted for more than 6 months; treated males subsequently achieved pregnancies with healthy offspring, although litter size remained smaller than that of young fertile dogs. Compared with 3-month administration, 1-week treatment was not associated with detectable changes in serum alkaline phosphatase (ALP).Discussion

These findings indicate that a 1-week letrozole course can restore spermatogenesis and fertility in aged azoospermic dogs, supporting its further evaluation as a low-exposure therapeutic strategy; larger, breed-stratified studies with extended safety profiling are recommended before clinical adoption.

Related

  1. Oncological outcomes of direct versus delayed surgery after neoadjuvant short-course radiotherapy for rectal cancer: national cohort study
    BJS openPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  2. Single-dose versus short-course antibiotic prophylaxis in laparoscopic right hemicolectomy with intracorporeal anastomosis: a retrospective cohort study
    Carmine Iacovazzo, Antonio Coviello, Andrea Uriel de Siena +8
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaCrossref
  3. Case Report: Prolonged survival with short-course triplet induction and dual maintenance in recurrent/metastatic cervical cancer
    Yiqing Duan, Dan Liu, Qian Huang +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefEurope PMCPMCEurope PMC
  4. [Comment] Node-sparing modified short-course radiotherapy combined with CAPOX and tislelizumab versus conventional short-course preoperative chemoradiotherapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer (mRCAT- Ⅲ): a multicenter, randomized, openlabel, phase 3 trial
    Liu Xiaojun, Li Laiyuan
    结直肠肛门外科Peer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  5. Evaluation of Short Versus Long Course of Tobramycin Combined with Piperacillin/Tazobactam Against Antibiotic-Resistant Pseudomonas aeruginosa in a Hollow Fibre Infection Model
    Yalew Wale, Jason Roberts, Hayoung Won +6
    AntibioticsPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyHAL
BibTeX
@article{liu2026shortcourse,
  title = {{Short-course letrozole restores fertility in aged azoospermic dogs.}},
  author = {Bao Liu and Lei Zhang and Fangzhou Zhu and Xin Jin and Taole Liu},
  journal = {Frontiers in veterinary science},
  year = {2026},
  month = oct,
  doi = {10.3389/fvets.2026.1939063},
  url = {https://europepmc.org/article/MED/42921373},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Short-course letrozole restores fertility in aged azoospermic dogs.
AU  - Bao Liu
AU  - Lei Zhang
AU  - Fangzhou Zhu
AU  - Xin Jin
AU  - Taole Liu
PY  - 2026
DA  - 2026/10/09
JO  - Frontiers in veterinary science
DO  - 10.3389/fvets.2026.1939063
UR  - https://europepmc.org/article/MED/42921373
AB  - Introduction  Age-related azoospermia is a clinically important cause of male infertility in dogs, yet effective pharmacological treatments for aged males remain limited. Whether transient aromatase inhibition can restore fertility in aged azoospermic dogs without prolonged exposure is unclear.Methods  This study evaluated whether a 1-week course of letrozole, an aromatase inhibitor, could restore spermatogenesis and fertility in aged azoospermic male dogs. Untreated aged azoospermic and young fertile dogs served as comparison groups, and a separate cohort of five aged dogs received 3 months of letrozole for safety assessment. Serum testosterone, semen parameters, testicular histology, fertilization-related transcripts, spermatogonia, seminal plasma metabolites, and serum biochemical markers of liver, kidney, and bone metabolism were assessed before and after treatment over a 6-month follow-up.Results  Serum testosterone increased within 1 week and peaked at approximately 2 weeks. Spermatozoa reappeared in ejaculates approximately 3 months after treatment and persisted for more than 6 months; treated males subsequently achieved pregnancies with healthy offspring, although litter size remained smaller than that of young fertile dogs. Compared with 3-month administration, 1-week treatment was not associated with detectable changes in serum alkaline phosphatase (ALP).Discussion  These findings indicate that a 1-week letrozole course can restore spermatogenesis and fertility in aged azoospermic dogs, supporting its further evaluation as a low-exposure therapeutic strategy; larger, breed-stratified studies with extended safety profiling are recommended before clinical adoption.
SN  - 2297-1769
ER  -